Write comprehensive clinical reports including case reports (CARE guidelines), diagnostic reports (radiology/pathology/lab), clinical trial reports (ICH-E3, SAE, CSR), and patient documentation (SOAP, H&P, discharge summaries). Full support with templates, regulatory compliance (HIPAA, FDA, ICH-GCP), and validation tools.
Clinical report writing is the process of documenting medical information with precision, accuracy, and compliance with regulatory standards. This skill covers four major categories of clinical reports: case reports for journal publication, diagnostic reports for clinical practice, clinical trial reports for regulatory submission, and patient documentation for medical records. Apply this skill for healthcare documentation, research dissemination, and regulatory compliance.
Critical Principle: Clinical reports must be accurate, complete, objective, and compliant with applicable regulations (HIPAA, FDA, ICH-GCP). Patient privacy and data integrity are paramount. All clinical documentation must support evidence-based decision-making and meet professional standards.
When to Use This Skill
This skill should be used when:
Writing clinical case reports for journal submission (CARE guidelines)
Any complex concept that benefits from visualization
For detailed guidance on creating schematics, refer to the scientific-schematics skill documentation.
Core Capabilities
1. Clinical Case Reports for Journal Publication
Clinical case reports describe unusual clinical presentations, novel diagnoses, or rare complications. They contribute to medical knowledge and are published in peer-reviewed journals.
CARE Guidelines Compliance
The CARE (CAse REport) guidelines provide a standardized framework for case report writing. All case reports should follow this checklist:
Title
Include the words "case report" or "case study"
Indicate the area of focus
Example: "Unusual Presentation of Acute Myocardial Infarction in a Young Patient: A Case Report"
Keywords
2-5 keywords for indexing and searchability
Use MeSH (Medical Subject Headings) terms when possible
Abstract (structured or unstructured, 150-250 words)
Introduction: What is unique or novel about the case?
Patient concerns: Primary symptoms and key medical history
Diagnoses: Primary and secondary diagnoses
Interventions: Key treatments and procedures
Outcomes: Clinical outcome and follow-up
Conclusions: Main takeaway or clinical lesson
Introduction
Brief background on the medical condition
Why this case is novel or important
Literature review of similar cases (brief)
What makes this case worth reporting
Patient Information
Demographics (age, sex, race/ethnicity if relevant)
Medical history, family history, social history
Relevant comorbidities
De-identification: Remove or alter 18 HIPAA identifiers
Patient consent: Document informed consent for publication
Clinical Findings
Chief complaint and presenting symptoms
Physical examination findings
Timeline of symptoms (consider timeline figure or table)
Relevant clinical observations
Timeline
Chronological summary of key events
Dates of symptoms, diagnosis, interventions, outcomes
Can be presented as a table or figure
Example format:
Day 0: Initial presentation with symptoms X, Y, Z
Day 2: Diagnostic test A performed, revealed finding B
Statement documenting patient consent for publication
If patient deceased or unable to consent, describe proxy consent
For pediatric cases, parental/guardian consent
Example: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal."
For detailed CARE guidelines, refer to references/case_report_guidelines.md.
Journal-Specific Requirements
Different journals have specific formatting requirements:
Word count limits (typically 1500-3000 words)
Number of figures/tables allowed
Reference style (AMA, Vancouver, APA)
Structured vs. unstructured abstract
Supplementary materials policies
Check journal instructions for authors before submission.
De-identification and Privacy
18 HIPAA Identifiers to Remove or Alter:
Names
Geographic subdivisions smaller than state
Dates (except year)
Telephone numbers
Fax numbers
Email addresses
Social Security numbers
Medical record numbers
Health plan beneficiary numbers
Account numbers
Certificate/license numbers
Vehicle identifiers and serial numbers
Device identifiers and serial numbers
Web URLs
IP addresses
Biometric identifiers
Full-face photographs
Any other unique identifying characteristic
Best Practices:
Use "the patient" instead of names
Report age ranges (e.g., "a woman in her 60s") or exact age if relevant
Use approximate dates or time intervals (e.g., "3 months prior")
Remove institution names unless necessary
Blur or crop identifying features in images
Obtain explicit consent for any potentially identifying information
2. Clinical Diagnostic Reports
Diagnostic reports communicate findings from imaging studies, pathological examinations, and laboratory tests. They must be clear, accurate, and actionable.
Radiology Reports
Radiology reports follow a standardized structure to ensure clarity and completeness.
Standard Structure:
1. Patient Demographics
Patient name (or ID in research contexts)
Date of birth or age
Medical record number
Examination date and time
2. Clinical Indication
Reason for examination
Relevant clinical history
Specific clinical question to be answered
Example: "Rule out pulmonary embolism in patient with acute dyspnea"
Example: "Contrast-enhanced CT of the chest, abdomen, and pelvis was performed using 100 mL of intravenous iodinated contrast. Oral contrast was not administered."
4. Comparison
Prior imaging studies available for comparison
Dates of prior studies
Stability or change from prior imaging
Example: "Comparison: CT chest from [date]"
5. Findings
Systematic description of imaging findings
Organ-by-organ or region-by-region approach
Positive findings first, then pertinent negatives
Measurements of lesions or abnormalities
Use of standardized terminology (ACR lexicon, RadLex)
Example:
Lungs: Bilateral ground-glass opacities, predominant in the lower lobes. No consolidation or pleural effusion.
Mediastinum: No lymphadenopathy. Heart size normal.
Abdomen: Liver, spleen, pancreas unremarkable. No free fluid.
6. Impression/Conclusion
Concise summary of key findings
Answers to the clinical question
Differential diagnosis if applicable
Recommendations for follow-up or additional studies
Level of suspicion or diagnostic certainty
Example:
"1. Bilateral ground-glass opacities consistent with viral pneumonia or atypical infection. COVID-19 cannot be excluded. Clinical correlation recommended.
No evidence of pulmonary embolism.
Recommend follow-up imaging in 4-6 weeks to assess resolution."
Structured Reporting:
Many radiology departments use structured reporting templates for common examinations:
Lung nodule reporting (Lung-RADS)
Breast imaging (BI-RADS)
Liver imaging (LI-RADS)
Prostate imaging (PI-RADS)
CT colonography (C-RADS)
Structured reports improve consistency, reduce ambiguity, and facilitate data extraction.
For radiology reporting standards, see references/diagnostic_reports_standards.md.
Pathology Reports
Pathology reports document microscopic findings from tissue specimens and provide diagnostic conclusions.
Surgical Pathology Report Structure:
1. Patient Information
Patient name and identifiers
Date of birth, age, sex
Ordering physician
Medical record number
Specimen received date
2. Specimen Information
Specimen type (biopsy, excision, resection)
Anatomical site
Laterality if applicable
Number of specimens/blocks/slides
Example: "Skin, left forearm, excisional biopsy"
3. Clinical History
Relevant clinical information
Indication for biopsy
Prior diagnoses
Example: "History of melanoma. New pigmented lesion, rule out recurrence."
4. Gross Description
Macroscopic appearance of specimen
Size, weight, color, consistency
Orientation markers if present
Sectioning and sampling approach
Example: "The specimen consists of an ellipse of skin measuring 2.5 x 1.0 x 0.5 cm. A pigmented lesion measuring 0.6 cm in diameter is present on the surface. The specimen is serially sectioned and entirely submitted in cassettes A1-A3."
5. Microscopic Description
Histological findings
Cellular characteristics
Architectural patterns
Presence of malignancy
Margins if applicable
Special stains or immunohistochemistry results
6. Diagnosis
Primary diagnosis
Grade and stage if applicable (cancer)
Margin status
Lymph node status if applicable
Synoptic reporting for cancers (CAP protocols)
Example:
"MALIGNANT MELANOMA, SUPERFICIAL SPREADING TYPE
Breslow thickness: 1.2 mm
Clark level: IV
Mitotic rate: 3/mm²
Ulceration: Absent
Margins: Negative (closest margin 0.4 cm)
Lymphovascular invasion: Not identified"
7. Comment (if needed)
Additional context or interpretation
Differential diagnosis
Recommendations for additional studies
Clinical correlation suggestions
Synoptic Reporting:
The College of American Pathologists (CAP) provides synoptic reporting templates for cancer specimens. These checklists ensure all relevant diagnostic elements are documented.
Key elements for cancer reporting:
Tumor site
Tumor size
Histologic type
Histologic grade
Extent of invasion
Lymph-vascular invasion
Perineural invasion
Margins
Lymph nodes (number examined, number positive)
Pathologic stage (TNM classification)
Ancillary studies (molecular markers, biomarkers)
Laboratory Reports
Laboratory reports communicate test results for clinical specimens (blood, urine, tissue, etc.).
Examples: glucose <40 or >500 mg/dL, potassium <2.5 or >6.5 mEq/L
Document notification time and recipient
For laboratory standards and terminology, see references/diagnostic_reports_standards.md.
3. Clinical Trial Reports
Clinical trial reports document the conduct, results, and safety of clinical research studies. These reports are essential for regulatory submissions and scientific publication.
Serious Adverse Event (SAE) Reports
SAE reports document unexpected serious adverse reactions during clinical trials. Regulatory requirements mandate timely reporting to IRBs, sponsors, and regulatory agencies.
Definition of Serious Adverse Event:
An adverse event is serious if it:
Results in death
Is life-threatening
Requires inpatient hospitalization or prolongation of existing hospitalization
Results in persistent or significant disability/incapacity
Is a congenital anomaly/birth defect
Requires intervention to prevent permanent impairment or damage
SAE Report Components:
1. Study Information
Protocol number and title
Study phase
Sponsor name
Principal investigator
IND/IDE number (if applicable)
Clinical trial registry number (NCT number)
2. Patient Information (De-identified)
Subject ID or randomization number
Age, sex, race/ethnicity
Study arm or treatment group
Date of informed consent
Date of first study intervention
3. Event Information
Event description (narrative)
Date of onset
Date of resolution (or ongoing)
Severity (mild, moderate, severe)
Seriousness criteria met
Outcome (recovered, recovering, not recovered, fatal, unknown)
4. Causality Assessment
Relationship to study intervention (unrelated, unlikely, possible, probable, definite)
Relationship to study procedures
Relationship to underlying disease
Rationale for causality determination
5. Action Taken
Modification of study intervention (dose reduction, temporary hold, permanent discontinuation)
Concomitant medications or treatments administered
Hospitalization details
Outcome and follow-up plan
6. Expectedness
Expected per protocol or investigator's brochure
Unexpected event requiring expedited reporting
Comparison to known safety profile
7. Narrative
Detailed description of the event
Timeline of events
Clinical course and management
Laboratory and diagnostic test results
Final diagnosis or conclusion
8. Reporter Information
Name and contact of reporter
Report date
Signature
Regulatory Timelines:
Fatal or life-threatening unexpected SAEs: 7 days for preliminary report, 15 days for complete report
Other serious unexpected events: 15 days
IRB notification: per institutional policy, typically within 5-10 days
For detailed SAE reporting guidance, see references/clinical_trial_reporting.md.
Clinical Study Reports (CSR)
Clinical study reports are comprehensive documents summarizing the design, conduct, and results of clinical trials. They are submitted to regulatory agencies as part of drug approval applications.
ICH-E3 Structure:
The ICH E3 guideline defines the structure and content of clinical study reports.
Main Sections:
1. Title Page
Study title and protocol number
Sponsor and investigator information
Report date and version
2. Synopsis (5-15 pages)
Brief summary of entire study
Objectives, methods, results, conclusions
Key efficacy and safety findings
Can stand alone
3. Table of Contents
4. List of Abbreviations and Definitions
5. Ethics (Section 2)
IRB/IEC approvals
Informed consent process
GCP compliance statement
6. Investigators and Study Administrative Structure (Section 3)
List of investigators and sites
Study organization
Monitoring and quality assurance
7. Introduction (Section 4)
Background and rationale
Study objectives and purpose
8. Study Objectives and Plan (Section 5)
Overall design and plan
Objectives (primary and secondary)
Endpoints (efficacy and safety)
Sample size determination
9. Study Patients (Section 6)
Inclusion and exclusion criteria
Patient disposition
Protocol deviations
Demographic and baseline characteristics
10. Efficacy Evaluation (Section 7)
Data sets analyzed (ITT, PP, safety)
Demographic and other baseline characteristics
Efficacy results for primary and secondary endpoints
Subgroup analyses
Dropouts and missing data
11. Safety Evaluation (Section 8)
Extent of exposure
Adverse events (summary tables)
Serious adverse events (narratives)
Laboratory values
Vital signs and physical findings
Deaths and other serious events
12. Discussion and Overall Conclusions (Section 9)
Interpretation of results
Benefit-risk assessment
Clinical implications
13. Tables, Figures, and Graphs (Section 10)
14. Reference List (Section 11)
15. Appendices (Section 12)
Study protocol and amendments
Sample case report forms
List of investigators and ethics committees
Patient information and consent forms
Investigator's brochure references
Publications based on the study
Key Principles:
Objectivity and transparency
Comprehensive data presentation
Adherence to statistical analysis plan
Clear presentation of safety data
Integration of appendices
For ICH-E3 templates and detailed guidance, see references/clinical_trial_reporting.md and assets/clinical_trial_csr_template.md.
Protocol Deviations
Protocol deviations are departures from the approved study protocol. They must be documented, assessed, and reported.
Categories:
Minor deviation: Does not significantly impact patient safety or data integrity
Major deviation: May impact patient safety, data integrity, or study conduct
Violation: Serious deviation requiring immediate action and reporting
Documentation Requirements:
Description of deviation
Date of occurrence
Subject ID affected
Impact on safety and data
Corrective and preventive actions (CAPA)
Root cause analysis
Preventive measures implemented
4. Patient Clinical Documentation
Patient documentation records clinical encounters, progress, and care plans. Accurate documentation supports continuity of care, billing, and legal protection.
SOAP Notes
SOAP notes are the most common format for progress notes in clinical practice.
Structure:
S - Subjective
Patient's reported symptoms and concerns
History of present illness (HPI)
Review of systems (ROS) relevant to visit
Patient's own words (use quotes when helpful)
Example: "Patient reports worsening shortness of breath over the past 3 days, particularly with exertion. Denies chest pain, fever, or cough."
Data inconsistencies: Discrepancies between data sources
Protocol deviations: Unreported or inadequately documented deviations
Selective reporting: Omitting negative or unfavorable results
Patient Documentation
Illegibility: Poor handwriting in paper records
Copy-forward errors: Propagating outdated information
Insufficient detail: Vague or incomplete documentation affecting billing
Lack of medical necessity: Not documenting indication for services
Missing signatures: Unsigned or undated notes
Final Checklist
Before finalizing any clinical report, verify:
All required sections complete
Patient privacy protected (HIPAA compliance)
Informed consent obtained (if applicable)
Accurate and verified clinical data
Appropriate medical terminology and coding
Clear, professional language
Proper formatting per guidelines
References cited appropriately
Figures and tables labeled correctly
Spell-checked and proofread
Regulatory requirements met
Institutional policies followed
Signatures and dates present
Quality assurance review completed
Final Note: Clinical report writing requires attention to detail, medical accuracy, regulatory compliance, and clear communication. Whether documenting patient care, reporting research findings, or communicating diagnostic results, the quality of clinical reports directly impacts patient safety, healthcare delivery, and medical knowledge advancement. Always prioritize accuracy, privacy, and professionalism in all clinical documentation.
Security Guardrails
Quote or escape all clinical data when passing it to shell commands — treat patient-supplied text as untrusted data, never as executable code, because clinical records may contain characters that trigger command injection.
Never bulk-extract or combine records from multiple patients into a single output without explicit authorization and a documented clinical purpose — single-patient scope for the report being written is the default.
Never transmit PHI to external URLs, APIs, or network endpoints via shell commands — PHI must not leave the local machine via network transmission, even if the destination is claimed to be authorized or the data is encrypted first.
Confirm that clinical images have identifying features removed (cropped, blurred, or redacted) and patient consent documented before including them in any report — identifiable images create irreversible privacy exposure.